Eckenstein-Geigy-Stiftung
VC Fund
Basel, Switzerland
Eckenstein-Geigy-Stiftung is a Swiss investment firm owned by the Eckenstein family. It invests money in companies such as technological startups across Switzerland. Eckenstein-Geigy-Stiftung has a headquarters in Basel in Switzerland.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 13%
Last updated:
For AI agents: llms.txt
Industries Eckenstein-Geigy-Stiftung invests in
Stages Eckenstein-Geigy-Stiftung invests in
Countries Eckenstein-Geigy-Stiftung invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Series A
- $2.4M–$4.4M
Investment Focus
Industry
- Health Care 4 (50%)
- Medical 2 (25%)
- Software 2 (25%)
- Medical Device 2 (25%)
- Information Technology 2 (25%)
Stage
- Series A 3 (38%)
- Pre-Seed 1 (13%)
- Series B 1 (13%)
- Series D 1 (13%)
- Funding Round 1 (13%)
Country
- Germany 2 (25%)
- Switzerland 2 (25%)
- Rwanda 1 (13%)
- United States 1 (13%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Gabriel Eckenstein
Foundation director
|
Foundation director | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
leon nanodrugs
|
leon nanodrugs a specialised product development company dedicated to developing a pipeline of enhanced versions of existing drug products, and providing services to enable pre-clinical and clinical stage formulations for their clients NCEs or branded established drugs.leon-nanodrugs offers access to the next generation of nano-formulated drugswith meaningful differentiation and added patient benefits.They specialize in improving the bioavailability of poorly water soluble drugs by using leon’s proprietary MJR® Technology platform to create either polymeric or crystalline nanoparticles. | Series D / Aug 06, 2024 | |
Ampersand
|
Ampersand catalyzes and power mass-market electric mobility. By supplying the battery swap network and operating system the company makes sustainable mobility rapidly accessible and affordable for developing markets, to improve livelihoods and the environment. With over a million km already covered by e-motorcycles in Africa using our plug-and-playpowertrain and energy network. | Venture - Series Unknown / Feb 15, 2024 | |
b-rayZ
|
b-rayZ is a spin-off of the University Hospital Zurich. Their team consists of professional radiologists, data scientists and physicians, with more than 15 years of work experience in medical imaging and radiology. They develop and provide predictive deep learning analytical tools and algorithms for the assessment of your personal medical images. | $4.1M / Series A / Jul 07, 2022 | |
Viebeg
|
Viebeg transform the way medical products are bought and sold, advancing the 4th industrial revolution in the developing world. | $1.5M / Pre-Seed / Oct 10, 2021 | |
NeoPrediX
|
NeoPrediX develops decision support tools with maternal, neonatal and perinatal screening platforms to evaluate, optimize and personalize medical strategies in pediatrics. We utilize intelligent algorithms and digital health solutions for neonatal and perinatal care based on deep medical data and science, developed by experienced scientists,pediatricians, and neonatologists. We transform medical data into intelligent predictions to support clinical decisions. | $4.8M / Mar 17, 2021 | |
|
NeoPrediX
|
NeoPrediX develops decision support tools with maternal, neonatal and perinatal screening platforms to evaluate, optimize and personalize medical strategies in pediatrics. We utilize intelligent algorithms and digital health solutions for neonatal and perinatal care based on deep medical data and science, developed by experienced scientists,pediatricians, and neonatologists. We transform medical data into intelligent predictions to support clinical decisions. | $4.4M / Series A / Mar 17, 2021 | |
|
leon nanodrugs
|
leon nanodrugs a specialised product development company dedicated to developing a pipeline of enhanced versions of existing drug products, and providing services to enable pre-clinical and clinical stage formulations for their clients NCEs or branded established drugs.leon-nanodrugs offers access to the next generation of nano-formulated drugswith meaningful differentiation and added patient benefits.They specialize in improving the bioavailability of poorly water soluble drugs by using leon’s proprietary MJR® Technology platform to create either polymeric or crystalline nanoparticles. | Series B / Apr 16, 2020 | |
Urban Farmers
|
Urban Farmers develops and builds urban agriculture systems with fish and plants for commercial growers and food retailers. The company develops rooftop farm solutions on commercial entities. | $2.4M / Series A / Apr 01, 2015 |
Co-Investors
TVM Capital Life Science
4 deals together
LifeCare Partners
3 deals together
Bayern Kapital
2 deals together
Beyond Capital Ventures
2 deals together
CD-Venture
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Eckenstein-Geigy-Stiftung invest in?
Eckenstein-Geigy-Stiftung invests primarily in Health Care, Medical and Software startups, most often at Series A and Pre-Seed stage. Most of the 8 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Eckenstein-Geigy-Stiftung's check size?
Eckenstein-Geigy-Stiftung typically joins rounds of $2.4M–$4.4M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Eckenstein-Geigy-Stiftung participates in.
How do I contact Eckenstein-Geigy-Stiftung?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Eckenstein-Geigy-Stiftung?
The team at Eckenstein-Geigy-Stiftung includes Gabriel Eckenstein (Foundation director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
